# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Baird analyst Michael Ha maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and raises the price target from $23 to ...
RBC Capital analyst Sean Dodge reiterates Privia Health Gr (NASDAQ:PRVA) with a Outperform and maintains $28 price target.
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.0...
Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the pric...
Baird analyst Michael Ha initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Outperform rating and announces Price T...